The Sperm Count Test Market is estimated to be valued at US$ 517.5 million in 2022 and is expected to exhibit a CAGR of 12.5% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Sperm count tests are medical tests conducted to measure the concentration of sperm in a man's semen or ejaculate and assess male fertility potential and the possible causes of infertility. The test provides useful information about the quality and quantity of a man's sperm and can help determine the ability to conceive naturally or the need for medical assistance.
Market key trends:
One of the key drivers of the sperm count test market is the rising male infertility rates globally. Male factor infertility contributes nearly 50% of infertility cases. With rising stress levels, pollution, obesity, and lifestyle changes, male infertility has increased considerably over the past few decades. A sedentary lifestyle, smoking, excessive alcohol intake, and exposure to toxins negatively impact sperm health and fertility in men. Thus, sperm evaluation through sperm count tests provides useful insights into male fertility status and the likelihood of conception. As male infertility continues to rise, demand for sperm count tests is expected to increase substantially during the forecast period. Increased awareness about male infertility diagnosis and management through government initiatives will further support the growth of this market.
Porter’s Analysis
Threat of new entrants: Low capital requirements and established distribution channel poses low threat of new entrants in the sperm count test market.
Bargaining power of buyers: Buyers have high bargaining power in the sperm count test market due to availability of substitutes and undifferentiated products.
Bargaining power of suppliers: Suppliers have low bargaining power due to fragmented nature of suppliers in the sperm count test market.
Threat of new substitutes: Threat of new substitutes is moderate as new testing methods can be introduced as substitutes.
Competitive rivalry: Intense due to global presence of many key players.
SWOT Analysis
Strength: Growing awareness about male infertility and introduction of advanced testing methods.
Weakness: Risk of incorrect results and need for experienced technicians to conduct the tests. Lack of reimbursement policies in developing regions.
Opportunity: Untapped potential in developing economies. Launch of home-use kits.
Threats: Social stigma associated with male fertility issues. Stringent regulations.
Key Takeaways
The global Sperm Count Test Market Trend is expected to witness high growth, exhibiting CAGR of 12.5% over the forecast period, due to increasing male infertility rates across the world. Asia Pacific region is projected to witness fastest growth in the sperm count test market during 2023-2030 due to increasing public health awareness, rising healthcare spending and surging fertility clinics in the region.
Key players operating in the sperm count test market are LLC Medical Group, Abbot Laboratories, CooperSurgical Inc., Hamilton Thorne Ltd., Medical Electronic Systems, Microptic S.L., ContraVac INC, MotilityCount Aps, DNA Diagnostics Center, Prestige Consumer Healthcare, Sandstone Diagnostics, bioMerieux SA, ASKA Pharmaceuticals, Clinical Genetics Pty Ltd, Halotech DNA, SAS MARKit, Trak Fertility, UEBE Medical GmbH, Vitrolife, Welling Home Health.
Comments
0 comment